Cellect Receives Notice of Intention to Grant from European Patent Office for Patent Protecting Company's Technology ...
GlobeNewswire (press release) The allowed claims relate to the engineering of regulatory immune cells with enhanced apoptotic activity to be used for immunomodulation in treating or preventing immune-related disorders. Earlier this year, Cellect received a Notice of Allowance from ... and more » |
April 03, 2017 at 05:08PM
http://ift.tt/2nA2nKr
from
http://ift.tt/2nA2nKr
No comments:
Post a Comment